comparemela.com

Latest Breaking News On - Commercialization efforts - Page 1 : comparemela.com

Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart

On November 21, 2023, Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an innovative IL-4Rα monoclonal antibody.

Nano-X Imaging Ltd (NASDAQ:NNOX) Q2 2023 Earnings Call Transcript

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q2 2023 Earnings Call Transcript August 17, 2023 Operator: Good morning, and thank you for standing by. Welcome to the Nano-X Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question and answer session. [Operator Instructions] Please […]

Kura Oncology Appoints Brian Powl as Chief Commercial Officer

SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Brian Powl as Chief Commercial Officer. Mr. Powl joins Kura with more than 20 years of experience in building commercial brands in hematology and oncology, with a focus on developing and executing patient-focused strategies across sales, marketing and ma

Should Universities Try to Capture More Value from Their Research?

Should Universities Try to Capture More Value from Their Research?
upenn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upenn.edu Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.